** Shares of British drugmaker Hikma Pharmaceuticals HIK.L fall ~11.5% to 1,568p
** HIK top loser in FTSE 100 .FTSE index
** Co cuts medium-term core operating profit growth forecast to 5% to 7%, down from the previous outlook of 7% to 9%
** Co expects medium-term compounded annual revenue growth to be at the lower end of the 6% to 8% range
** Up to Wednesday close, HIK down 11.14% YTD, compared with a 19.57% increase in FTSE
(Reporting by Unnamalai L in Bengaluru)
((Unnamalai.L@thomsonreuters.com;))